Christopher J. Ryerson

2010–2025 年に発表

170
論文数
32,186
被引用数
69
h 指数
162
i10 指数

被引用数

Christopher J. Ryerson の年別被引用数1994 年: 被引用 1 件2004 年: 被引用 1 件2007 年: 被引用 3 件2008 年: 被引用 2 件2009 年: 被引用 1 件2010 年: 被引用 1 件2011 年: 被引用 1 件2012 年: 被引用 8 件2013 年: 被引用 32 件2014 年: 被引用 76 件2015 年: 被引用 99 件2016 年: 被引用 104 件2017 年: 被引用 185 件2018 年: 被引用 177 件2019 年: 被引用 946 件2020 年: 被引用 1,499 件2021 年: 被引用 1,634 件2022 年: 被引用 1,301 件2023 年: 被引用 1,111 件2024 年: 被引用 1,935 件2025 年: 被引用 803 件2026 年: 被引用 31 件1995〜2003 年は被引用が無いため表示していません2005〜2006 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,006 件、この内訳の 19.3%中国: 引用元論文 998 件、この内訳の 9.6%イギリス: 引用元論文 787 件、この内訳の 7.6%イタリア: 引用元論文 733 件、この内訳の 7%日本: 引用元論文 591 件、この内訳の 5.7%ドイツ: 引用元論文 529 件、この内訳の 5.1%カナダ: 引用元論文 515 件、この内訳の 5%フランス: 引用元論文 491 件、この内訳の 4.7%スペイン: 引用元論文 321 件、この内訳の 3.1%オーストラリア: 引用元論文 311 件、この内訳の 3%オランダ: 引用元論文 277 件、この内訳の 2.7%韓国: 引用元論文 253 件、この内訳の 2.4%
0%19.3%その他 24.8%

分野

  • Medicine91.7%
  • Biochemistry, Genetics and Molecular Biology3.3%
  • Health Professions1.1%
  • Immunology and Microbiology0.9%
  • Engineering0.8%
  • Environmental Science0.4%
  • その他1.8%

トピック

  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis21.3%
  • Chronic Obstructive Pulmonary Disease (COPD) Research5.4%
  • Systemic Sclerosis and Related Diseases5.4%
  • Sarcoidosis and Beryllium Toxicity Research3.8%
  • Inflammatory Myopathies and Dermatomyositis3.3%
  • Long-Term Effects of COVID-192.9%
  • その他57.9%

共著者

全論文

検索で開く
  1. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lawrence Ho, Julie Morisset, Amy L. Olson, Anna Podolanczuk, Venerino Poletti, Moisés Selman, Thomas Ewing, Stephen Jones, Shandra L. Knight, Marya Ghazipura, Kevin C. Wilson - American Journal of Respiratory and Critical Care Medicine 2022 被引用: 2,618

  2. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Moisés Selman, William D. Travis, Simon Walsh, Kevin C. Wilson - American Journal of Respiratory and Critical Care Medicine 2018 被引用: 4,100

  3. An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shandra Protzko, Ganesh Raghu, Luca Richeldi, Nicola Sverzellati, Jeffrey J. Swigris, Dominique Valeyre - American Journal of Respiratory and Critical Care Medicine 2013 被引用: 4,273

  4. Idiopathic pulmonary fibrosis: Disease mechanisms and drug development

    著者: , , , , , , , , - Pharmacology & Therapeutics 2020 被引用: 652

  5. Diagnosis of Hypersensitivity Pneumonitis in Adults: An Official ATS/JRS/ALAT Clinical Practice Guideline

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lisa A. Maier, Carlos Matiz, Ferrán Morell, Andrew G. Nicholson, Setu Patolia, Carlos A.C. Pereira, Elisabetta Renzoni, Margaret L. Salisbury, Moisés Selman, Simon Walsh, Wim Wuyts, Kevin C. Wilson - American Journal of Respiratory and Critical Care Medicine 2020 被引用: 1,012

  6. Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2016 被引用: 1,444

  7. Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society

    著者: , , , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2020 被引用: 570

  8. Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper

    著者: , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2017 被引用: 1,022

  9. Pulmonary Rehabilitation for Adults with Chronic Respiratory Disease: An Official American Thoracic Society Clinical Practice Guideline

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2023 被引用: 389

  10. A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis

    著者: , , , , , , , , , , , - Annals of Internal Medicine 2012 被引用: 1,313

  11. Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Coimbatore Sree Vidya, Rebecca R. Baron, Timothy Clouser, Tracy J. Doyle, Anthony H. Maeda, Kristin B. Highland, Jemima F. Albayda, Sarah E. Collins, Karthik Suresh, John M. Davis, Andrew H. Limper, Isabel Amigues, Kristina Eliopoulos, Jeffery J. Swigris, Stephen M. Humphries, John Huntwork, Chris Glynn, Steve Duncan, Maria I. Danila, Marilyn K. Glassberg, Elana M. Oberstein, Elizabeth A. Belloli, Linda Briggs, Vivek Nagaraja, Linda Cholewa, Donna DiFranco, Edward Green, Christie Liffick, Tanvi Naik, Genevieve Montas, Dorota Lebiedz‐Odrobina, Reba Bissell, Mark H. Wener, Lisa Lancaster, Leslie J. Crawford, Karmela K Chan, Robert J. Kaner, Alicia Morris, Xiaoping Wu, Nader Khalidi, Christopher J. Ryerson, Alyson W. Wong, Charlene D. Fell, Sharon LeClercq, Mark Hyman, Shane Shapera, Shikha Mittoo, Shireen Shaffu, Karl Gaffney, Andrew M. Wilson, Shaney Barratt, Harsha Gunawardena, Rachel K. Hoyles, Joel David, Namrata Kewalramani, Toby M. Maher, Philip L. Molyneaux, Maria Kokosi, Matthew Cates, Mandizha Mandizha, Abdul Ashish, Gladstone Chelliah, Helen Parfrey, Muhunthan Thillai, Josephine Vila, Sophie Fletcher, Paul Beirne, C Favager, Jo Brown, Julie Dawson ほか 7 名 - The Lancet Respiratory Medicine 2022 被引用: 208

  12. Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long-COVID symptoms

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2022 被引用: 223

  13. Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2022 被引用: 185

  14. Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis

    著者: , , , , , , , - European Respiratory Review 2023 被引用: 215

  15. Predicting Survival Across Chronic Interstitial Lung Disease

    著者: , , , , , , , , , , - CHEST Journal 2013 被引用: 565

  16. The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Radiology 2020 被引用: 1,127

  17. Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Athol U. Wells - American Journal of Respiratory and Critical Care Medicine 2022 被引用: 226

  18. Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis. Results of the INJOURNEY Trial

    著者: , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2017 被引用: 297

  19. YouTube Videos as a Source of Misinformation on Idiopathic Pulmonary Fibrosis

    著者: , , , , - Annals of the American Thoracic Society 2019 被引用: 163

  20. Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)

    著者: , , , , , , , , , - Annals of the Rheumatic Diseases 2020 被引用: 253

  21. The Role of Chest Imaging in Patient Management During the COVID-19 Pandemic

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - CHEST Journal 2020 被引用: 1,304

  22. Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline

    著者: , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2020 被引用: 301

  23. Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical Trial

    著者: , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2024 被引用: 65

  24. Progression of fibrosing interstitial lung disease

    著者: , , - Respiratory Research 2020 被引用: 184